Patents by Inventor Yoshie REIEN

Yoshie REIEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic agent for diabetes
    Patent number: 10759749
    Abstract: A nobel therapeutic agent for diabetes which can suppress occurrence of side effects such as persistent hypoglycemia is provided. The active ingredient is a derivative of 1,1-diphenylsemicarbazide or 1,1-diphenylthiosemicarbazide. In particular, the active ingredient is a derivative of 1,1-diphenyl-4-cyclohexyl-semicarbazide or 1,1-diphenyl-4-cyclohexyl-thiosemicarbazide exhibiting hypoglycemic action when orally administered.
    Type: Grant
    Filed: August 28, 2017
    Date of Patent: September 1, 2020
    Assignees: JCR Pharmaceuticals Co., Ltd., National University Corporation Kone University, National University Corporation Chiba University
    Inventors: Susumu Seino, Kenji Sugawara, Ichiro Mori, Akio Matsumoto, Yoshie Reien
  • NOVEL THERAPEUTIC AGENT FOR DIABETES
    Publication number: 20190202781
    Abstract: A nobel therapeutic agent for diabetes which can suppress occurrence of side effects such as persistent hypoglycemia is provided. The active ingredient is a derivative of 1,1-diphenylsemicarbazide or 1,1-diphenylthiosemicarbazide. In particular, the active ingredient is a derivative of 1,1-diphenyl-4-cyclohexyl-semicarbazide or 1,1-diphenyl-4-cyclohexyl-thiosemicarbazide exhibiting hypoglycemic action when orally administered.
    Type: Application
    Filed: August 28, 2017
    Publication date: July 4, 2019
    Applicants: JCR Pharmaceuticals Co., Ltd., National University Corporation Kobe University, National University Corporation Chiba University
    Inventors: Susumu SEINO, Kenji SUGAWARA, Ichiro MORI, Akio MATSUMOTO, Yoshie REIEN